Catalent
CTLT
#1860
Rank
A$15.86 B
Marketcap
A$87.38
Share price
0.00%
Change (1 day)
1.91%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): A-$9.66

According to Catalent's latest financial reports the company's current EPS (TTM) is A-$8.71. In 2023 the company made an earnings per share (EPS) of A-$9.36 a decrease over its 2022 EPS that were of A$3.12.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)A-$9.663.17%
2023A-$9.36-399.56%
2022A$3.12-30.58%
2021A$4.5079.67%
2020A$2.51114.12%
2019A$1.17-15%
2018A$1.3875.44%
2017A$0.78-22.97%
2016A$1.02-59.56%
2015A$2.52282.05%
2014A$0.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
A-$0.94-89.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
A-$7.97-8.53%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
A-$1.03-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
A-$2.04-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA